BackIntegra Lifesciences Holdings Overview
Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Target Price

Analysts' 12-month price predictions for IART.

Get informed when a big investor buys or sells

+ Follow

Share Price

$16.1

Average Target Price

$12.0025.5% downside

1 analysts in the last 4 months

High: $12 | Low: $12

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-04-15Truist FinancialRichard Newitter$1225.5% downsideOpen
2025-10-15Truist Financial$156.8% downsideOpen
2024-10-07BTIGRyan Zimmerman$2024.2% upsideOpen
2024-07-30Truist FinancialRichard Newitter$2661.5% upsideOpen
2024-07-30CitigroupJoanne Wuensch$2342.9% upsideOpen
2024-07-29BTIGRyan Zimmerman$2236.6% upsideOpen
2024-07-16Truist FinancialRichard Newitter$3298.8% upsideOpen
2024-05-07Truist FinancialRichard Newitter$2555.3% upsideOpen
2024-05-07JMP SecuritiesDavid Turkaly$40148.4% upsideOpen
2024-05-06Wells FargoVik Chopra$2555.3% upsideOpen
2022-10-26Piper SandlerMatt O'Brien$50210.6% upsideOpen
2022-07-28Piper SandlerFY22 EPS$55241.6% upsideOpen
2021-05-20JefferiesAnthony Petrone$86434.2% upsideOpen
2021-04-29RBC CapitalShagun Singh Chadha$74359.6% upsideOpen
2021-04-29Wells FargoLarry Biegelsen$74359.6% upsideOpen